1.
KL Wu, M Beksac, J van Droogenbroeck, S Amadori, S Zweegman, P Sonneveld. Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma. haematol [Internet]. 2006Jan.1 [cited 2021Feb.27];91(12):1722-3. Available from: https://haematologica.org/article/view/4254